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Abstract
Human genome-wide association studies (GWAS), transcriptome analyses of animal models, and candidate gene studies
have advanced our understanding of the genetic architecture of aggressive behaviors. However, each of these methods
presents unique limitations. To generate a more confident and comprehensive view of the complex genetics underlying
aggression, we undertook an integrated, cross-species approach. We focused on human and rodent models to derive eight
gene lists from three main categories of genetic evidence: two sets of genes identified in GWAS studies, four sets implicated
by transcriptome-wide studies of rodent models, and two sets of genes with causal evidence from online Mendelian
inheritance in man (OMIM) and knockout (KO) mice reports. These gene sets were evaluated for overlap and pathway
enrichment to extract their similarities and differences. We identified enriched common pathways such as the G-protein
coupled receptor (GPCR) signaling pathway, axon guidance, reelin signaling in neurons, and ERK/MAPK signaling. Also,
individual genes were ranked based on their cumulative weights to quantify their importance as risk factors for aggressive
behavior, which resulted in 40 top-ranked and highly interconnected genes. The results of our cross-species and integrated
approach provide insights into the genetic etiology of aggression.
Introduction
Aggressive behavior is an evolutionarily conserved, heri-
table trait that is essential for survival and fitness. In
humans, aggressive behavior is also shaped by societal and
cultural constraints. Context-inappropriate aggression can
cause great harm to society, families, and individuals, and
has been associated with neuropsychiatric disorders, such as
attention-deficit/hyperactivity disorder (ADHD) [1, 2],
schizophrenia (SCZ), and bipolar disorder (BIP) [3–5].
The heritability of human aggression has been estimated
around 50% [6]. Its complex genetic architecture interacts
with environmental factors [7–9]. Decades of animal studies
have yielded strong neurochemical and physiological evi-
dence that points to conserved common pathways across
species such as serotoninergic and dopaminergic neuro-
transmission and hormonal signaling [10]. These data
helped to inform candidate gene selection for human studies
on serotonergic and dopaminergic genes (MAOA, 5HTT,
HTR1B, HTR2A, DAT, DRD2, DRD4), as well as hormone-
related genes (AR, ESR1, AVP, OXTR) [11]. However, the
largest meta-analysis of candidate genes performed to date
[12] did not find any significant association. Genome-wide
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association studies (GWAS) of aggression have been
underpowered to detect common variants of small pene-
trance associated with complex phenotypes [11, 12]. The
largest GWAS, which was performed by the Early Genetics
and Lifecourse Epidemiology (EAGLE) consortium (http://
research.lunenfeld.ca/eagle/), reported association with one
SNP, rs11126630, at a suggestive significance level (p=
5.3e−08). Among the “classical” candidates evaluated in
the EAGLE dataset, only one gene, AVPR1A, encoding the
arginin vasopressin receptor 1A, showed a nominal asso-
ciation with aggression (p= 1.6e−03) [13].
Studies of rare human genetic conditions [14] and gene
knockouts (KOs) in mice [15, 16] show that many genetic
determinants play critical roles in shaping the emotional
circuitry of the brain and modulating aggressive behavior
[17, 18]. For example, rare mutations in the gene encoding
methyl-CpG-binding protein 2 (MeCP2), a chromatin-
associated protein involved in transcription regulation,
cause Rett syndrome, mental retardation, and increased
aggression [19]. Mecp2 KO mice also show increased
aggression [20]. Another example is the gene for prion
protein, the mutation of which causes inherited prion dis-
eases and aggressive behavior in humans [21]. Mice with
depleted prion protein showed increased aggressiveness
[22], possibly related to the role of the prion protein in
regulating cytoskeleton and associated proteins [23].
Despite convincing evidence supporting these high-risk
genes from human single-gene disorders and KO mice
studies, none have reached genome-wide significance in
GWAS of aggression. The best p-value was for gene
LRRC7 in a study of children (p= 4e−06) [24]. LRRC7
interacts with cytoskeleton molecules and is involved in
synaptic spine structure and patterning [25]. Lrrc7 KO mice
show significantly increased fighting among littermates
[26]. Nevertheless, similar pathways such as synaptic
development, axon guidance, and MAPK signaling emerge
when examining genes from the top GWAS findings (p ≤ 5e
−05, ref. [11]). These pathways were also enriched in genes
identified through transcriptomic studies of animal models
of aggression in mice [27, 28], rats [29], zebrafish [30], and
Drosophila [31]. With increasing sample sizes, some of
these genes and, perhaps, additional risk loci may emerge in
future GWAS.
Meanwhile, we postulate that a cross-species and inte-
grated approach combining different modalities of genetic
data can yield a clearer understanding of the genetics of
aggression. Our study focuses on several categories of
available genome-wide data: (1) genes derived from human
GWAS studies: we updated and expanded the GWAS genes
catalog from [11]. (2) Genes found in transcriptome studies
of rodent models (brain tissue): we obtained the raw
expression data from four unique selective-bred rodent
models and re-analyzed them to identify strain-specific
genes differentially expressed in high- versus low-
aggressive lines. (3) Previously published sets of human
genes implicated in aggression phenotypes in human single-
gene disorders cataloged in online Mendelian inheritance in
man (OMIM) [14] and mouse genes implicated in KO
studies [15]. This latter category comprises high risk and
possibly causal genes because single-gene changes results
in (or modifies) the individual’s aggressive behavior.
Although each of these studies have intrinsic limitations, the
convergence of evidence by cross-referencing and inte-
grating the available data may lead to a more comprehen-
sive and confident understanding of the genetic basis of




We updated previous reported GWAS genes for aggression
[11] with studies published until August 2016, discarding
those that were performed in samples of individuals with
other psychiatric disorders (such as drug dependence or
BIP). Selected GWAS included four studies for the adult
GWAS gene set [32–35] and five for the child gene set [13,
36–39]. Two studies were GWAS meta-analyses [13, 32].
For detailed procedures, see Supplementary Figure 1. Eli-
gible SNPs and retrieved genes are in Supplementary
Table 1. As a negative control, we generated a gene list
from the GWAS catalog (https://www.ebi.ac.uk/gwas/) by
combining signals from 14 phenotypes not related to the
nervous system in samples of individuals with European
ancestry and sample sizes that are similar to those of the
nine GWAS of aggressive behaviors. We used the same
procedures to retrieve associated signals and nearby genes
(Supplementary Table 2).
Genes from rodent model transcriptomes
Genome-wide transcriptome data were available for four
genetic rodent models of aggression: three inbred mouse
strains [28] and one rat strain [29] along with their com-
parable low-aggression strains. Data had been generated
using Affymetrix Mouse Genome 430 2.0 or Rat Genome
U34 microarrays, and acquired from the Gene Expression
Omnibus (dataset series GSE29552) [29] or the author [28].
The mouse strains from the study by Malki et al. were (1)
Turku aggressive and Turku non-aggressive mice selected
from a colony of Swiss albino mice in Turku (Finland)
based on high male–male aggression in a dyadic test
against non-aggressive mice [40]; (2) short attack latency
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and long attack latency mice bred from a wild-type Mus
musculus domesticus population in Groningen, Holland by
selecting on average attack latency in a resident-intruder test
[41]; (3) North Carolina aggressive (NC900) and non-
aggressive (NC100) mice selected from out-bred NCR mice
in North Carolina (USA) showing increased aggression and
reactivity to stimulation [42]. For convenience, we use
country of origin to denote the strains: Finland, Holland,
and USA, respectively. The rat model data were derived
from selectively bred high responder (bHR) and low
responder (bLR) Sprague-Dawley rats. These groups
showed differences in emotional reactivity and exploratory
behavior, aggression, impulsivity, and proclivity to psy-
chostimulant abuse [43, 44]. We used weighted gene co-
expression network analysis [45] to identify strain-specific
genes in co-expression modules significantly associated
with aggression (for details of methods, see
Supplementary File 1; gene sets were listed in Supple-
mentary Table 3).
OMIM and KO mice genes
We used previously published sets of human genes impli-
cated in aggression phenotypes in human single-gene dis-
orders cataloged in OMIM (N= 85) [14] and mouse genes
implicated in KO studies (N= 89) [15]. Genes in these two
sets were included in Supplementary Table 4.
Genetic correlation (LD score) analyses between
aggression and psychiatric disorders
We estimated the genetic correlation of aggression with six
other psychiatric disorders (ADHD, SCZ, BIP, autism
spectrum disorders (ASDs), major depression (MDD) and
post-traumatic stress disorders (PTSDs), by LD score
(LDSC) regression analysis [46]. We used the largest
aggression GWAS meta-analysis of children samples, the
EAGLE (Early Genetics and Lifecourse Epidemiology
Consortium) study [13] and a recently published GWAS of
antisocial behavior by Tielbeek et al. [47], which included
64% adult and 36% child samples. None of the four adult
aggression samples reported so far have either sufficient
sample sizes or summary statistics available. For ADHD,
SCZ, BIP, ASD, MDD, and PTSD, the sources of summary
statistics are in Supplementary Table 5.
Gene set overlap analysis and gene ranking
Rodent transcriptome genes were converted to human
orthologues using biomaRt [48, 49]. Gene overlap among the
sets was evaluated using one-tailed Fisher’s exact tests. We
ranked individual genes by their total numbers of occurrences
in these lists. We also ranked them using a simple
weighted sum method: aggression gene rank= 1 × (total
occurrence in human GWAS studies)+ 0.5 × (total occur-
rence in four rodent model transcriptome lists)+ 1.5 × (total
occurrence in OMIM and KO mice genes). The rationale
was to add 50% more weight to the genes in OMIM or
in KO mice lists compared with the GWAS genes lists
because alterations in the first set of genes are more firmly
linked to aggression. We discounted the weight to 0.5 for the
rodent transcriptome genes given the limitations of these
studies, including the limited phenotypes used in selective
breeding, small sample sizes, the limited brain regions and
age ranges studied, and the potential for confounding cause
and effect in such studies. This weighting scheme also
ensured that the maximum possible ranking scores from all
four rodent models would be 2, equal to the maximum
possible score of the two GWAS lists. The three main
categories of studies (human GWAS, rodent transcriptome
studies, and the high-risk gene set combining KO mice and
OMIM genes) were evaluated for overlap using Fisher’s
exact test.
Ingenuity pathway analysis: pathway and network
analysis
Individual gene sets were imported to ingenuity pathway
analysis (IPA) to assess canonical pathway enrichment.
The negative log of Fisher’s exact test p-values are
reported. Using a p < 0.05 cutoff, we coded the pathway
enrichment as a binary variable for the subsequent
analysis, with 1 indicating significant enrichment and 0
no enrichment. We examined the pathway enrichment
similarities among the gene sets with classical metric
multidimensional scaling (MDS) using the Rogers-
Tanmoto correlation for binary data [50] in STATA 14.
The configuration for the first four-dimensional Euclidean
space was visualized in a 4D plot (a, b, c, and node
size) created in R. We explored the activation/inhibition
states of the top enriched canonical pathways using
IPA’s activation Z-score tool. Because gene expression
changes are needed to calculate activation Z-scores and
because shared pathway enrichment is needed for the
activation comparison, this analysis was only performed
on the USA mice and the rat models. Finally, we used
IPA’s network generation algorithm to identify the highly
interconnected networks of the top 40 ranked genes
according to the weighted method described in the pre-
vious section. These networks were visualized using IPA’s
Path Designer tool. We imported the networks into
Cytoscape to measure the number of interactions (degree)
of the top-ranked 40 genes with other genes in the network.
Logarithms of the degree estimates were compared for
rodent versus human aggression genes using quantile
regression.




A total of 175 and 281 genes were selected from four adult
and five children GWAS gene sets, respectively (Supple-
mentary Figure 1 and Supplementary Table 1). Six genes
were present in both sets: ALK, LAMA2, NFKB1, OSMR,
RBFOX1, and WDR62 (significant overlap by Fisher’s exact
test, p= 0.038, Table 1). The control GWAS gene list
comprises 172 genes (Supplementary Table 2); only one
gene was shared with either the adult (ARHGEF3) or the
child (LY86) datasets (non-significant). LDSC regression
found a significant positive correlation between the EAGLE
GWAS meta-analysis of aggression in children [13] and
ADHD (p= 9.75e−05), and positive correlations between
the recently published GWAS meta-analysis of antisocial
behavior [47] with ADHD (p= 4.4e−03) and MDD (p=
3.53e−03). No significant genetic correlations were found
with any other disorders examined (SCZ, ASD, BIP, and
PTSD), or between the aggression GWAS meta-analyses
(Supplementary Figure 2).
Rodent transcriptome genes
One gene module was significantly downregulated in bHR
rats compared to the bLR rats (ME6, Benjamini-Hochberg
(BH)-corrected p < 0.05). For the mouse models, one
module for each line was significantly downregulated in
high-aggression versus low-aggression lines (Finland:
ME12, uncorrected p-value <0.005, BH p-value <0.2;
Holland: ME29, BH p < 0.05; USA: ME11, BH p < 0.05).
One module was significantly upregulated for the Holland
aggressive versus non-aggressive line (ME22, p-value=
8.4e−04, BH p-value= 0.028). Supplementary Figure 3
plots the eigengene expression for all five significant rodent
modules.
We combined the two modules for the Holland lines for
downstream analyses. This yielded one significantly asso-
ciated gene set for each single rodent model for a total of
four gene sets. The gene sets and eigengene expression for
individual genes in each module are shown in Supple-
mentary Table 3. The Holland mice shared 12 genes with
the USA lines (p= 0.013) and 13 with the Finland lines (p
= 0.002) (Table 1). The Finland and USA lines shared 11
genes (non-significant). The rat model shared five genes
with the Finland and Holland lines (non-significant) and 10
with the USA lines (p= 0.01).
Comparison of gene lists and gene ranking
The human GWAS and rodent transcriptome gene sets were
cross-referenced with previously published OMIM and KO
mice gene sets [15, 51] (Supplementary Table 4). Table 1
summarizes the overlap among all possible pairs and the
Fisher’s exact test p-values. Although the number of
Table 1 Gene list overlaps
Gene overlap GWAS_Adult GWAS_Child KO_Mice Mice_Finland Mice_Holland Mice_USA OMIM Rat
(N/p-values) (N= 175) (N= 281) (N= 89) (N= 381) (N= 271) (N= 397) (N= 85) (N= 211)
GWAS_Child 6
(N= 281) p= 0.038
KO_Mice 1 4
(N= 89) p= 0.544 p= 0.037
Mice_Finland 1 6 6
(N= 381) p= 0.269 p= 0.662 p= 0.007
Mice_Holland 2 2 1 13
(N= 271) p= 1 p= 0.597 p= 1 p= 0.002
Mice_USA 3 11 4 11 12
(N= 397) p= 1 p= 0.029 p= 0.102 p= 0.193 p= 0.013
OMIM 1 3 4 3 1 1
(N= 85) p= 0.528 p= 0.118 p= 0.001 p= 0.221 p= 1 p= 1
Rat 1 4 6 5 5 10 3
(N= 211) p= 1 p= 0.546 p < 0.0001 p= 0.606 p= 0.215 p= 0.010 p= 0.061
GWAS_Contrl 1 1 2 1 4 2 1 2
(N= 172) p= 1 p= 0.737 p= 0.179 p= 0.389 p= 0.301 p= 0.779 p= 0.522 p= 0.704
The total number of genes in each lists and shared numbers of genes across different list is tabulated. Fisher’s exact test was used to evaluate the
lists overlap based on ~22,000 total known genes for rodents and human. Significant overlaps (p < 0.05, uncorrected) are highlighted as bold












































































































































































































































































































































































































































































































































































































































































































































































































































































































































An integrated analysis of genes and functional pathways for aggression in human and rodent models
overlapping genes was small, some reached statistical sig-
nificance. Notably, the USA mouse shared 11 genes with
the child GWAS gene list (p= 0.029), and the KO mice set
shared four genes with the child GWAS genes (p= 0.037),
four with the human OMIM genes (p= 0.001), six with the
Finland mouse (p= 0.007), and six with the rat model (p <
0.001). None of the eight aggression gene lists showed any
significant overlap with the GWAS control gene set.
Supplementary Table 4 lists all the 1767 genes from the
eight aggression gene sets (adult and children GWAS,
transcriptomics in four rodent models, KO mice and
OMIM) and ranks them based on their number of occur-
rences and weighted ranks for aggression (only human
orthologs were included from the rodent genes). MAOA was
ranked highest with both methods. One hundred and nine-
teen genes appeared in at least two lists. Forty of them have
a weighted ranking score ≥2 (Table 2) and almost all are
involved in neuronal functions: synaptic transmission (n=
13, GO: 0007268, p= 5e−09), nervous system develop-
ment (n= 18, GO: 0007399, p= 7e−08), synapse (n= 11,
GO: 0045202, p= 1e−08), neuron projection (n= 9, GO:
0043005, p= 2e−05), and neuroactive ligand–receptor
interaction (n= 5, KEGG: 04080, p= 2e−04). Detailed
information on individual genes and references to the ori-
ginal studies are shown in Supplementary Table 6.
Analysis of overlap among the three main categories
human GWAS, rodent transcriptome, and high-risk genes
(i.e., KO mice and OMIM genes) revealed one gene,
ERBB4, with supporting evidence from all three categories.
A total of nine GWAS genes were also high-risk genes (p=
0.007), and 22 rodent transcriptome genes were high-risk
genes (p < 0.0001). However, the overlap between GWAS
and transcriptome genes (n= 29) was not statistically sig-
nificant (p= 0.29). The Venn diagram in Fig. 1a shows
these overlaps.
Pathway analysis
We performed canonical pathway enrichment analysis for
each aggression gene set. Eleven pathways were significant
in at least three aggression gene sets (highlighted in red in
Supplementary Table 7) and included axonal guidance
signaling, CREB signaling in neurons, ERK/MAPK sig-
naling, G-protein coupled receptor (GPCR) signaling,
GABA, and serotonin receptor signaling and reelin signal-
ing. The most shared pathways between any two sets were
11 pathways in common in the OMIM and KO mice gene
sets, followed by eight shared pathways between the child
GWAS and USA mice and seven between the child GWAS
and the rat model. The adult GWAS only shared four
pathways with the USA mouse and one with the rat model,
although it did share five pathways with the OMIM list.
There were no common significantly enriched pathways
among all three mouse strains. The Finland and Holland
Fig. 1 Venn diagram of gene and pathway overlaps from three categories of genetic evidence. a Number of gene overlaps. One gene, ERBB4, was
shared in all three categories. A total of nine GWAS genes were also high-risk genes (p= 0.007), and 22 rodent transcriptome genes were high-risk
genes (p < 0.0001). In contrast, the overlap between the human GWAS and the rodent transcriptome genes (n= 29) was not statistically significant
(p= 0.29). b Shared canonical pathway enrichments. The total pathway overlap between the human GWAS and high-risk genes (N= 9, p=
0.015) and the overlap between the rodent transcriptome and high-risk genes (N= 48, p= 0.005) were significant. In contrast, the pathway overlap
between the human GWAS and rodent transcriptome genes was not significant (N= 27, p= 0.20). Red numbers indicate significant overlaps.
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mouse strains had almost no overlap with other gene lists.
The child and adult GWAS sets shared only one pathway,
phospholipase C signaling. The percentage of enriched
pathways shared with any other gene list out of the total
enriched canonical pathways for each list were ranked as
follows: OMIM 59%, USA mouse 53%, KO mice 48%,
Child GWAS and Rat both 44%, adult GWAS 43%, Fin-
land mouse 20% and Holland 11%.
MDS was used to analyze the pathway enrichment
similarities shared by the different gene sets. The 4D plot
(Supplementary Figure 4 and Supplementary File 2) shows
that six sets of aggression genes (two human GWAS,
OMIM genes, and all three mouse models) were closely
clustered in the first three dimensions, which explained
71.6% of the total variance. The rat model, the KO mice
genes, and GWAS control genes were distinctly separable
in the first three dimensions. The child GWAS genes mainly
loaded on the fourth dimension, which accounted for an
additional 12.4% of the variance. The USA mouse model
mainly loaded in the fifth dimension, which accounted for
an additional 8.6% of the variance (not shown).
Examining the common pathways shared by the three
main categories of genetic evidence returned seven cano-
nical pathways (Table 3). Among them, five contained top-
ranked genes and the G-protein-coupled receptor signaling
pathway was also significantly enriched with the top-ranked
genes (p= 0.002). As seen for the analysis of gene overlap,
the total pathway overlap between the human GWAS and
high-risk genes (N= 9, p= 0.015) and the overlap between
the rodent transcriptome and high-risk genes were sig-
nificant (N= 48, p= 0.005). In contrast, the pathway
overlap between the human GWAS and rodent tran-
scriptome genes was not significant (N= 27, p= 0.20). The
Venn diagram in Fig. 1b shows this overlap.
The IPA activation Z-score analysis performed on the
shared canonical pathways between the USA mice and rat
gene sets predicted mostly opposite activities except for
one: dopamine DARPP32 feedback in cAMP signaling.
This pathway was inhibited in both models (Supplementary
Figure 5).
Network analysis of the top genes
The 40 top-ranked genes were highly interconnected in
three tightly clustered networks identified by IPA’s network
generation algorithm using direct relationships from the
Ingenuity® Knowledge Base. These networks were related
to nervous system development and function, neurological
disease and psychological disorders, and cellular function
and maintenance (Fig. 2). The total number of interactions
with other genes, i.e, degree, was significantly higher for the
human compared with the rodent aggression genes (F(1, 22)
= 10.59, p= 0.004). Genes from both human and rodent
studies also had a significantly higher degree than the
rodent-only genes (F(1, 28)= 4.97, p= 0.034), but this
degree is not different from that of the human-only genes
(Supplementary Figure 6).
Discussion
Our study integrates all prior human and rodent genetic
studies of aggression to overcome their individual limita-
tions and to gain a more robust insight into the genetic
etiology of aggression. We found that genes from these
different types of studies share some significant overlap at
both the gene and biological pathway levels. Their lack of
overlap with a control GWAS set confirms that they harbor
genetic information relevant to aggression. The two main
categories, human GWAS genes and rodent transcriptome
genes, however, did not overlap significantly, although they
both shared significant overlap with distinct subsets of the
high-risk genes (those obtained from human OMIM phe-
notypes and KO mice). This pattern was also true for the
pathway enrichments. This suggests differences in
the genetic etiology of human and rodent aggression or the
possibility that human GWAS and transcriptomic studies of
rodent brains capture different sets of genes involved in the
etiology of aggression. Finally, using a weighted ranking
method, we provided a hierarchical list of genes associated
with aggression.
Table 3 Canonical pathways
shared by all three categories of
genes
Canonical pathways Human GWAS genes Rodent transcriptome genes Causal genes
Signaling by Rho family GTPases 2.294 1.594 1.847
ERK/MAPK signaling 2.093 2.238 2.965
G-protein-coupled receptor signaling 1.999 3.971 9.286
Axonal guidance signaling 1.947 1.714 2.499
Reelin signaling in neurons 1.939 1.759 1.432
Molecular mechanisms of cancer 1.647 2.591 3.075
Gαs signaling 1.609 2.054 5.589
The negative log p-values of enrichment assessed by Fisher’s exact test were reported in the table
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Fig. 2 IPA network analysis of the 40 top-ranked genes. Network A is
involved in behavior, nervous system development and function, and
cell-to-cell signaling and interaction (score 35, 15 genes). Network B
is involved in neurological disease, psychological disorders, nervous
system development and function (score 29, 13 genes). Network C is
involved in organismal functions, cellular function and maintenance,
small molecule biochemistry (score 26, 12 genes). Genes highlighted
in color correspond to the 40 top-ranked genes. In purple, human-only
aggression genes (from GWAS and OMIM studies), in blue, rodent-
only aggression genes (rodent model transcriptomic genes and KO
mice genes), and in orange, genes from both human and rodent studies.
Y. Zhang-James et al.
The adult and child GWAS sets had only six genes in
common: ALK, LAMA2, NFKB1, OSMR, RBFOX1, and
WDR62. Albeit small, this overlap was statistically sig-
nificant. All six genes are essential for neurodevelopment.
ALK encodes a tyrosine kinase receptor linked to neuro-
blastoma [52]. LAMA2 encodes an extracellular matrix
protein. Its mutation causes denervation atrophy of the
muscle [53]. OSMR is a member of the type-I cytokine
receptor family and is essential for the development of a
subtype of nociceptive neurons in the dorsal root ganglia
[54]. NFKB1 is a transcription factor involved in regulating
responses of neurons to activation of different signaling
pathways in a variety of physiological and pathological
conditions [55]. RBFOX1 is a splicing factor implicated in
many neurodevelopmental and psychiatric disorders and
several evidences have highlighted this gene as a candidate
for aggression [56, 57]. WDR62 is a centrosomal and
nuclear protein linked to autosomal recessive microcephaly
[58, 59].
Most genes in the adult and child GWAS sets did not
overlap. The two sets only shared one canonical pathway.
Furthermore, the EAGLE GWAS meta-analysis of chil-
dren’s aggression [13] and the Tielbeek’s GWAS of anti-
social behavior (64% adult) [47] do not show genetic
correlation. The sample size of children in Tielbeek’s
GWAS was only half of the EAGLE’s, likely too small for
LDSC regression and explaining their lack of correlation
despite the presence of children samples in both datasets.
More importantly, the results highlight the possible genetic
differences, although it may be due to phenotype differ-
ences between the two samples. Indeed, aggressive beha-
viors often manifest in different forms and are triggered by
different risk factors across the lifespan [60]. Some
aggressive behaviors in childhood predict aggression in
later life; others are temporary and disappear at later ages,
such as temper tantrums in toddlers [61] and adolescence-
limited antisocial behavior [62]. Adult onset aggression is
often linked to physical or emotional trauma, substance use,
medical illnesses, or brain injuries [60]. Our LDSC
regression found significant correlations between the
EAGLE’s child sample and ADHD, and between Tielbeek’s
sample (64% adults) with both ADHD and MDD. The
results support pleiotropic effects of shared common DNA
variants on the comorbidity of aggression with ADHD in
children, or with MDD in adults. The lack of genetic cor-
relations of either dataset with SCZ, BIP, autism, or PTSD
suggests that for these disorders, aggression may arise from
different causal factors. Future studies are needed to fully
address the genetic bases of the comorbidity between
aggression and psychiatric disorders.
Among the rodent models, few biological pathways were
shared, although there was some significant gene overlap.
Differences in selective breeding may have fixed different
genes into these models. Considering that the Finland and
Holland lines were selectively bred based on a single
behavioral criterion, either increased aggression toward
non-aggressive mice [40] or decreased attack latency
toward intruder mice [41], it is not surprising to see that
they had the lowest numbers of enriched pathways and
overlap with other lists. Our results suggest that their utility
in modeling human aggression may be limited because the
underlying genetic risk factors may be different from one
another and more importantly from the genetic predisposi-
tion to aggression in humans. This notion was further
supported by our network analysis of the 40 top-ranked
genes, which showed that genes with evidence only from
rodent studies have a fewer number of interactions in the
network than those genes derived from human studies,
suggesting more restricted functional impact of rodent
genes on the network.
In contrast, the USA mice and the rat lines showed many
overlapping pathways with the human GWAS genes, most
notably with the child set. The USA mice and the rat model
were bred for varying phenotypes: increased reactivity
toward stimulation [42], novelty exploration, impulsivity,
and vulnerability to psychostimulant abuse [29, 44]. Con-
sidering that human aggression is often accompanied by
these traits, the USA mouse (NC900/NC100) and rat (bHR/
bLR) lines may be better suited to model human aggression,
particularly in the context of psychiatric comorbidities.
However, their shared biological pathways often showed
opposite inhibition/activation activities and, although sta-
tistically significant, the two lines shared <5% of genes
(Table 1). Thus, it seems likely that different mechanisms,
having some shared components, regulate aggression in
these two models. The only consistent directional change of
these shared pathways between the two rodent models, the
downregulation of the dopamine-DARPP32 feedback in
cAMP signaling, was also found altered in the ventral
striatum and the frontal cortex of an operant mouse model
of frustration showing aggressive behavior [63].
The most notable overlap observed in our analyses was
for the 11 pathways shared between the human OMIM and
the KO mice genes. Because the OMIM phenotypes are
typically multidimensional phenotypes including medical,
psychiatric, and aggressive features, it has not heretofore
been clear whether the aggression observed in affected
individuals was a direct genetic effect or if it was mediated
via another phenotype. The substantial overlap with the KO
mouse gene set provides strong evidence that the aggression
in these OMIM disorders has a genetic etiology.
Among the top enriched pathways, several were pre-
viously well-known pathways for aggression: the dopamine,
serotonin, glutamate, and GABA signaling pathways
(Supplementary Table 7). Some of the pathways we found
were not previously linked to aggression directly. However,
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there are several reasons to view them as functionally
associated with aggression. For example, the GPCR sig-
naling pathway, which was significantly enriched in our
data (Table 3), mediates much receptor signaling including
serotonin, dopamine, metabolic glutamate receptors, oxy-
tocin and vasopressin receptors. ERK/MAPK and Rho-
GTPase signaling form intracellular signaling cascades that
orchestrate cellular responses of GPCR signaling. Axonal
guidance and reelin signaling are important pathways for
nervous system development and have been implicated in
neuropsychiatric disorders such as bipolar, SCZ, and
ADHD [64–68], which are often associated with aggres-
sion. Indeed, several recent reviews in human and animals
have consistently identified these pathways [11, 15, 51].
Novel pathways that have never been linked to aggression
offer us new perspectives on the pathophysiology of
aggression. One interesting example is cancer signaling.
Although it has never been implicated in aggression, it is
not uncommon for cancer patients to display changed per-
sonalities and even violent behaviors [69]. The close rela-
tionship of cancer signaling with immune system offers a
plausible mechanism linking cancer with many neu-
ropsychiatric conditions including aggression.
Finally, one notable finding is that our ranked gene list
highlights 40 top genes (Table 2 and Supplementary
Table 6), all of which are involved in neurotransmission,
axon guidance, synaptic plasticity, learning and memory,
neuronal development, or hormone signaling. Twenty-three
of the top genes had reports of KO mice studies, strongly
supporting their role in aggression. One particular gene of
our interest is RBFOX1, a splicing factor important for
neuronal development. Interestingly, the protein encoded by
RBFOX1 regulates the expression of 15 of the top 40 ranked
genes (the probability of this event is p= 3.4e−05) [70].
Convergent data from GWAS, neuroimaging genetics,
epigenetics, gene expression, and animal models supports
RBFOX1 as a strong candidate for aggression [57]. Fur-
thermore, all 40 genes are highly connected in three func-
tional networks (Fig. 2). Human disease genes tend to
interact with each other with higher network connectivity
than non-disease genes [71]. Many studies of complex
neuropsychiatric disorders have also concluded that disease-
causing variants are often clustered in protein-interaction
networks with a high degree of connectivity among them-
selves and that these clustered networks are often enriched
with functional pathways relevant to brain functions
[72–80]. We observed both characteristics for our top-
ranked genes, which strongly supports a multifactorial
genetic landscape for aggression and the roles of these top
genes in aggression. The clusters formed by the top-ranked
genes are not only crucial keys for deciphering molecular
mechanisms underlying the pathophysiology of aggression;
they may also harbor useful therapeutic targets.
We noted that non-genetic models, such as stress-
induced aggression [27, 81] and other organisms [30, 31,
82], were not included in this study. However, some cor-
respondences with our findings are worth mentioning
(details in Supplementary File 1). These consistencies
support the utility of a cross-species approach like ours for
identifying genetic mechanisms that are evolutionarily
conserved and that may underlie gene-by-environment
interactions.
Our approach inherits the limitations of the original
studies. GWAS were underpowered and the resulting gene
sets may include many false positives. KO mice studies are
biased by authors’ choices. For example, genes reported to
cause aggression in OMIM disorders may be more likely
selected for gene KO in animal models. Although these KO
models validate the role of these genes in aggression, it
limits our ability to understand the true degree of overlap.
The rodent genetic models had been defined by simple
behavioral criteria, which may not be generalizable to other
species. Improving aggression studies, for example by
increasing GWAS sample sizes or by building a repository
of behavioral phenotypes for gene KOs in mice, could
certainly improve accuracy and decrease the noise in inte-
grative studies like ours. Including other species and model
organisms may also provide additional insights; however,
difficulty remains regarding gene orthology and general-
ization of behaviors across distant species.
In summary, we integrated genomic and transcriptomic
studies from different species and provided valuable
insights into the complex genetic signatures that underlie
aggression in both humans and rodent models. Our ranked
lists of genes and pathways provide guidance for functional
studies in the future.
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